Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $3.3 million.

  • Orchestra BioMed Holdings' Other Operating Expenses fell 156.22% to -$515,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $137,000, marking a year-over-year decrease of 94.33%. This contributed to the annual value of $3.3 million for FY2024, which is 37.34% up from last year.
  • As of FY2024, Orchestra BioMed Holdings' Other Operating Expenses stood at $3.3 million, which was up 37.34% from $2.4 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Other Operating Expenses high stood at $3.3 million for FY2024, and its period low was -$951,000 during FY2022.
  • In the last 3 years, Orchestra BioMed Holdings' Other Operating Expenses had a median value of $2.4 million in 2023 and averaged $1.6 million.
  • Data for Orchestra BioMed Holdings' Other Operating Expenses shows a peak YoY surged of 350.89% (in 2023) over the last 5 years.
  • Orchestra BioMed Holdings' Other Operating Expenses (Yearly) stood at -$951,000 in 2022, then surged by 350.89% to $2.4 million in 2023, then spiked by 37.34% to $3.3 million in 2024.